Er Jin Selected Research

Gefitinib (Iressa)

1/2017

Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Er Jin Research Topics

Disease

5	Neoplasms (Cancer) 02/2024 - 01/2017
5	Lung Neoplasms (Lung Cancer) 01/2024 - 11/2016
2	Adenocarcinoma of Lung 02/2024 - 01/2024
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017 - 11/2016
1	Adenocarcinoma 01/2024
1	Genomic Instability 11/2017
1	Carcinogenesis 11/2016

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2019
2	RetinoidsIBA 01/2019 - 11/2017
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 02/2024
1	Tryptophan (L-Tryptophan)FDA Link 02/2024
1	KynurenineIBA 02/2024
1	ErbB Receptors (EGF Receptor)IBA 01/2024
1	6- trimethylsilylthio- 9- trimethylsilylpurineIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 12/2022
1	EnzymesIBA 12/2022
1	ImmunosorbentsIBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Tumor Suppressor Protein p53IBA 11/2017
1	LC capilliposideIBA 01/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016

Therapy/Procedure

2	Therapeutics 01/2024 - 12/2022
1	Aftercare (After-Treatment) 01/2024